ChemInform Abstract: The Highly Potent and Selective Dipeptidyl Peptidase IV Inhibitors Bearing a Thienopyrimidine Scaffold Effectively Treat Type 2 Diabetes.
Cheminform（2011）
摘要
Novel thienopyrimidine analogues (IV) and (VI) of alogliptin demonstrate potent and selective DPP-IV inhibitory activity.
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要